Menu Search
Equities

Acotec Scientific Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7W3:FRA

Acotec Scientific Holdings Ltd

Actions
  • Price (EUR)1.45
  • Today's Change-0.01 / -0.68%
  • Shares traded332.00
  • 1 Year change+90.79%
  • Beta1.1039
Data delayed at least 15 minutes, as of Feb 16 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Acotec Scientific Holdings Ltd is a company engaged in interventional medical device business. The Company is primarily engaged in the research and development on providing treatment solutions for vascular diseases, involving drug-coated balloons (DCB) and percutaneous transluminal angioplasty balloon catheters (PTA). The Company’s main products include AcoArt Orchid & Dhalia, AcoArt Tulip & Litos, AcoArt Iris & Jasmin, AcoArt Lily & Rosmarin, Peripheral Aspiration System (AcoStream), Radiofrequency Ablation System (AcoArt Cedar), 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream) and others, covering fields such as vascular surgery, cardiology, nephrology and neurology. The Company conducts businesses within domestic and overseas markets.

  • Revenue in HKD (TTM)671.46m
  • Net income in HKD114.28m
  • Incorporated2020
  • Employees645.00
  • Location
    Acotec Scientific Holdings Ltd4F to 5F, Building 1No. 16, Hongda North Road, Beijing Econoand Technological Development ZoneBEIJING 100176ChinaCHN
  • Websitehttps://www.acotec.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.